Sign In
to Vote &
Create Storyboards.
 
Experimental Malaria Vaccine Protects Half Of People Who Tried It Sanaria Inc.'s experimental malaria vaccine PfSPZ protects half of the study participants who tried it for at least a year. To date, this is the longest duration of malaria protection from an experimental vaccine.
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard